Stay updated on Isatuximab Combo in High-Risk Smoldering MM Clinical Trial

Sign up to get notified when there's something new on the Isatuximab Combo in High-Risk Smoldering MM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Isatuximab Combo in High-Risk Smoldering MM Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    New screenshot shows only minor visual/layout adjustments on the Record History page; no substantive changes to version entries or study information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-02T00:55:51.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    32 days ago
    Change Detected
    Summary
    Introducing a major update notice and current operating status guidance, along with a new version tag v3.2.0; the old version tag v3.1.0 has been removed.
    Difference
    10%
    Check dated 2025-10-04T12:28:35.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    - Version updated from v3.0.2 to v3.1.0. This indicates a new release/build; no other content changes are indicated.
    Difference
    0.2%
    Check dated 2025-09-27T08:01:30.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Updated the page revision from v3.0.1 to v3.0.2 and removed the 'Back to Top' UI element.
    Difference
    0.6%
    Check dated 2025-09-13T01:44:30.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1.
    Difference
    0.6%
    Check dated 2025-09-05T19:53:18.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location details, which are crucial for users seeking specific information about studies. Additionally, multiple study statuses and identification details have been added, enhancing the overall content related to study availability and eligibility.
    Difference
    39%
    Check dated 2025-08-29T16:54:09.000Z thumbnail image

Stay in the know with updates to Isatuximab Combo in High-Risk Smoldering MM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Isatuximab Combo in High-Risk Smoldering MM Clinical Trial page.